VYXEOS reimbursement information and patient support
CMS approval of new technology add-on payment (NTAP)
VYXEOS is the ONLY sAML chemotherapy granted NTAP status by Centers for Medicare & Medicaid Services (CMS), meeting the definition of newness, substantial clinical improvement relative to existing therapies, and cost thresholds.
J code issued for VYXEOS
Dedicated JazzCares specialists are available to assist patients who have started treatment, in either the inpatient or outpatient setting, with reimbursement for VYXEOS.
Help understanding insurance coverage
Provide resources to help patients understand their insurance coverage and find information on sources of financial support
Help paying for medication
- Provides eligible patients with assistance for out-of-pocket costs, subject to annual maximum
Free-drug program for eligible patients
- Designed to provide Jazz products at no cost to patients who are uninsured or deemed uninsured due to lack of coverage for a Jazz product
- Subject to financial and residency eligibility criteria
Call the patient support hotline 1-855-5VYXEOS (1-855-589-9367), Monday through Friday between 8 AM and 8 PM ET to speak with a representative.
*Insurance coverage and plans may vary. The JazzCares Program provides general information only and is not a guarantee of any coverage or reimbursement outcome. All treatment decisions rest solely with the treating physician or qualified healthcare professional.
You can also request to be contacted by an Access and Reimbursement Manager (ARM) to assist you with additional reimbursement-related questions.